SK15602002A3 - Cyclipostin, spôsob jeho výroby a farmaceutický prípravok s jeho obsahom - Google Patents

Cyclipostin, spôsob jeho výroby a farmaceutický prípravok s jeho obsahom Download PDF

Info

Publication number
SK15602002A3
SK15602002A3 SK1560-2002A SK15602002A SK15602002A3 SK 15602002 A3 SK15602002 A3 SK 15602002A3 SK 15602002 A SK15602002 A SK 15602002A SK 15602002 A3 SK15602002 A3 SK 15602002A3
Authority
SK
Slovakia
Prior art keywords
formula
compound
physiologically acceptable
cyclipostin
alkyl
Prior art date
Application number
SK1560-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Laszlo Vertesy
Klaus Ehrlich
Michael Kurz
Joachim Wink
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of SK15602002A3 publication Critical patent/SK15602002A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SK1560-2002A 2000-05-04 2001-04-25 Cyclipostin, spôsob jeho výroby a farmaceutický prípravok s jeho obsahom SK15602002A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10021731A DE10021731B4 (de) 2000-05-04 2000-05-04 Cyclipostine, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung derselben
PCT/EP2001/004652 WO2001083497A1 (fr) 2000-05-04 2001-04-25 Cyclipostines, leur procede de production et leur utilisation

Publications (1)

Publication Number Publication Date
SK15602002A3 true SK15602002A3 (sk) 2003-04-01

Family

ID=7640768

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1560-2002A SK15602002A3 (sk) 2000-05-04 2001-04-25 Cyclipostin, spôsob jeho výroby a farmaceutický prípravok s jeho obsahom

Country Status (27)

Country Link
EP (1) EP1280812B1 (fr)
JP (1) JP5038572B2 (fr)
KR (1) KR100779867B1 (fr)
CN (1) CN1216890C (fr)
AR (1) AR028398A1 (fr)
AT (1) ATE288442T1 (fr)
AU (2) AU6222901A (fr)
BR (1) BR0110459A (fr)
CA (1) CA2407808C (fr)
CZ (1) CZ20023547A3 (fr)
DE (2) DE10021731B4 (fr)
DK (1) DK1280812T3 (fr)
EE (1) EE05090B1 (fr)
ES (1) ES2236234T3 (fr)
HR (1) HRP20020864A2 (fr)
HU (1) HUP0300306A3 (fr)
IL (2) IL152612A0 (fr)
MX (1) MXPA02010297A (fr)
NO (1) NO330438B1 (fr)
NZ (1) NZ522352A (fr)
PL (1) PL358328A1 (fr)
PT (1) PT1280812E (fr)
RU (1) RU2266911C2 (fr)
SK (1) SK15602002A3 (fr)
WO (1) WO2001083497A1 (fr)
YU (1) YU81502A (fr)
ZA (1) ZA200208928B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2383300T3 (es) 2003-11-13 2012-06-20 Hanmi Holdings Co., Ltd Fragmento Fc de IgG para un vehículo de fármacos y procedimiento para su preparación
US8110665B2 (en) 2003-11-13 2012-02-07 Hanmi Holdings Co., Ltd. Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
KR100754667B1 (ko) 2005-04-08 2007-09-03 한미약품 주식회사 비펩타이드성 중합체로 개질된 면역글로불린 Ｆｃ 단편 및이를 포함하는 약제학적 조성물
EP1894601A1 (fr) 2006-08-29 2008-03-05 sanofi-aventis traitement des infections mycobacterielles avec des cyclipostines
KR200453850Y1 (ko) * 2008-04-23 2011-05-30 주식회사 에이티티알앤디 수질 관리 센서 내장형 수도미터기
KR102073748B1 (ko) 2013-01-31 2020-02-05 한미약품 주식회사 재조합 효모 형질전환체 및 이를 이용하여 면역글로불린 단편을 생산하는 방법
AR096891A1 (es) 2013-07-12 2016-02-03 Hanmi Pharm Ind Co Ltd Conjugado de monómero polipéptido biológicamente activo y conjugado de fragmento fc de inmunoglobulina, que muestra aclaramiento mediado por receptor reducido, y el método para la preparación del mismo

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04145089A (ja) * 1990-10-05 1992-05-19 Nippon Kayaku Co Ltd 抗生物質ｎｋ９０１０９３、その製造法及びそれを有効成分として含有する殺虫・殺ダニ剤
AU649116B2 (en) * 1991-03-27 1994-05-12 Sankyo Company Limited New compounds, named the "Leustroducins", their preparation and their therapeutic uses
JPH0656859A (ja) * 1991-07-25 1994-03-01 Nippon Kayaku Co Ltd 抗生物質ｎｋ９０１０９３ａ、その製造法及びそれを有効成分として含有する殺虫・殺ダニ剤
RU2077204C1 (ru) * 1995-05-12 1997-04-20 Третьяков Анатолий Петрович Способ производства микробиологических препаратов

Also Published As

Publication number Publication date
BR0110459A (pt) 2003-03-11
CA2407808A1 (fr) 2002-10-30
CA2407808C (fr) 2013-06-25
KR100779867B1 (ko) 2007-11-27
AU2001262229B2 (en) 2007-01-25
EE05090B1 (et) 2008-10-15
JP2003531914A (ja) 2003-10-28
ZA200208928B (en) 2003-10-07
DE50105249D1 (de) 2005-03-10
WO2001083497A1 (fr) 2001-11-08
IL152612A (en) 2009-11-18
NO20025209L (no) 2002-10-30
ES2236234T3 (es) 2005-07-16
YU81502A (sh) 2006-05-25
CN1427845A (zh) 2003-07-02
HK1055745A1 (en) 2004-01-21
AR028398A1 (es) 2003-05-07
EE200200599A (et) 2004-04-15
ATE288442T1 (de) 2005-02-15
IL152612A0 (en) 2003-06-24
EP1280812B1 (fr) 2005-02-02
HUP0300306A3 (en) 2004-10-28
KR20030009464A (ko) 2003-01-29
NZ522352A (en) 2004-06-25
HUP0300306A2 (hu) 2003-06-28
DK1280812T3 (da) 2005-05-30
NO20025209D0 (no) 2002-10-30
EP1280812A1 (fr) 2003-02-05
NO330438B1 (no) 2011-04-11
CN1216890C (zh) 2005-08-31
JP5038572B2 (ja) 2012-10-03
PT1280812E (pt) 2005-05-31
DE10021731B4 (de) 2005-12-08
CZ20023547A3 (cs) 2003-02-12
HRP20020864A2 (en) 2004-12-31
AU6222901A (en) 2001-11-12
MXPA02010297A (es) 2003-04-25
DE10021731A1 (de) 2001-11-15
PL358328A1 (en) 2004-08-09
RU2266911C2 (ru) 2005-12-27

Similar Documents

Publication Publication Date Title
FI101978B (fi) Menetelmä leustroduksiinien valmistamiseksi
SK15602002A3 (sk) Cyclipostin, spôsob jeho výroby a farmaceutický prípravok s jeho obsahom
EP0001709B1 (fr) Antibiotiques du groupe de la déoxynarasine, leur procédé de préparation et leur utilisation
RU2134694C1 (ru) Аминоолигосахарид ск-4416, способ его получения, ингибитор сахаридгидролазы и антибактериальный агент
KR100245477B1 (ko) 폴리히드록시시클로펜탄 유도체, 그의 제조방법 및 그의 치료적 용도
CA1252058A (fr) Derives de l'acide griseolique inhibiteurs d'enzymes et leurs application
US6756402B2 (en) Cyclipostins, process for their preparation and use thereof
CA1230567A (fr) Cl-1957a antibiotique et methode de production
US4780311A (en) Antihypercholesterolemic tri-yne carbonates
US6380257B1 (en) Aromatic di-keto derivatives, processes for their production and their use as a pharmaceutical
JP2971204B2 (ja) 新規物質ｗｋ−２９５５およびその製造法
US5436231A (en) Adenophostins
JPH01240196A (ja) 新規グリコペプチド系抗生物質ｐａ−４５０５２
IE913430A1 (en) Anticoccidial and growth promoting polycyclic ether¹antibiotic